PALI CIK: 1357459

Palisade Bio Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
11.5
FY22:
14.7
FY23:
13.3
FY24:
10.5
FY25:
134
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.01
FY22:
1.03
FY23:
0.72
FY24:
0.39
FY25:
0.12
Total assets
Change from FY21 to FY25
millions USD
FY21:
12.5
FY22:
15.8
FY23:
14.1
FY24:
10.9
FY25:
134

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.50
FY22:
3.01
FY23:
2.59
FY24:
3.24
FY25:
4.64
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.65
FY22:
0.27
FY23:
0.15
FY24:
0.15
FY25:
0.33
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.37
FY22:
12.5
FY23:
11.3
FY24:
7.49
FY25:
129
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
12.5
FY22:
15.8
FY23:
14.1
FY24:
10.9
FY25:
134

All amounts in millions USD Data source:SEC EDGAR